No definition available.
Endpoint definition
↥Report an error or suggest an improvement for this endpoint codes
Endpoint definition steps |
FinnGen |
|---|---|
Phenotype data |
519972 |
1. Apply sex-specific ruleNone |
519972 |
2. Check conditionsNone |
519972 |
3. Check pre-conditions, main-only, mode, registry filtersRegistry filters: 2 out of 7 registries used, show all original rules. |
52 |
4. Check minimum number of eventsNone |
52 |
5. Include endpointsNone |
52 |
6. Filter based on genotype QC (FinnGen only) |
50 |
Control definitions (FinnGen only)
- Control exclude
- Q17_OTHER_CONGEN_MALFO
Extra metadata
- First used in FinnGen datafreeze
- DF12
Similar endpoints
↥List of similar endpoints to
Alport
based on the number of shared cases.
Similar with more cases:
- Other specified congenital malformation syndromes affecting multiple systems
- Exclusion endpoint for clefts
- Clefts and syndromes for tooth agenesis exclusion, including avohilmo
- Other congenital malformations
- Other congenital malformations
Similar with less cases:
None
Case counts by codes
↥FinnGen case counts by registry codes:
No upset plot: unknown.
No upset table: unknown.
Summary Statistics
↥-FinRegistry-
This endpoint is excluded (different definition than used in FinnGen).
-FinnGen-
Key figures
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 50 | 21 | 29 |
| Unadjusted period prevalence (%) | 0.01 | 0.01 | 0.01 |
| Median age at first event (years) | 26.00 | 24.38 | 27.17 |
-FinnGen-
Age distribution of first events
-FinnGen-
Year distribution of first events
-FinnGen-
Cumulative Incidence Function
No data
CodeWAS (R11)
↥CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.
This is a new tool, please reach out using the contact form for feedback and improvement ideas.
First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.
Matched cohort
- Matched cases
- 52
- Matched controls
- 520
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
Q8780, ,
ICD-10 Finland
Alport syndrome
+∞
74.4
52
*
A98, ,
ICD-O-3
+∞
71.7
51
*
J01CA04, ,
ATC
amoxicillin; systemic
+∞
64.9
48
*
J01DB01, ,
ATC
cefalexin; oral
+∞
61.0
46
*
SAA02, ,
ICD-O-3
+∞
55.5
43
*
WX110, ,
ICD-O-3
+∞
50.5
40
*
SAA01, ,
ICD-O-3
+∞
48.9
39
*
N02BE01, ,
ATC
paracetamol; systemic, rectal
+∞
45.7
37
*
EB1HA, ,
ICD-O-3
+∞
39.8
33
*
EB1SA, ,
ICD-O-3
+∞
39.8
33
*
K021, ,
ICD-O-3
+∞
38.3
32
*
SFA10, ,
ICD-O-3
+∞
36.9
31
*
SAA03, ,
ICD-O-3
+∞
36.9
31
*
J01CE02, ,
ATC
phenoxymethylpenicillin; oral
+∞
36.9
31
*
Z012, ,
ICD-O-3
+∞
35.5
30
*
J01FA10, ,
ATC
azithromycin; systemic
+∞
34.2
29
*
H903, ,
ICD-10 Finland
Sensorineural hearing loss, bilateral
+∞
32.8
28
*
SFA20, ,
ICD-O-3
+∞
32.8
28
*
R4110, ,
ICD-O-3
+∞
32.8
28
*
J01CR02, ,
ATC
amoxicillin and beta-lactamase inhibitor; systemic
+∞
32.8
28
*
A02BC02, ,
ATC
pantoprazole; systemic
+∞
32.8
28
*
M01AE01, ,
ATC
ibuprofen; systemic, rectal
+∞
32.8
28
*
EB1AA, ,
ICD-O-3
+∞
31.5
27
*
GD1AA, ,
ICD-O-3
+∞
31.5
27
*
Z2221, ,
ICD-O-3
+∞
30.1
26
*
ZXD10, ,
ICD-O-3
+∞
30.1
26
*
Z3231, ,
ICD-O-3
+∞
30.1
26
*
R03AC02, ,
ATC
salbutamol; inhalant
+∞
30.1
26
*
J01AA02, ,
ATC
doxycycline; systemic
+∞
30.1
26
*
WZC00, ,
ICD-O-3
+∞
28.8
25
*
ZXE00, ,
ICD-O-3
+∞
28.8
25
*
C03CA01, ,
ATC
furosemide; systemic
+∞
28.8
25
*
J01DA01, ,
ATC
[U] cefalexin
+∞
28.8
25
*
ZXE10, ,
ICD-O-3
+∞
28.8
25
*
WX290, ,
ICD-O-3
+∞
27.5
24
*
123, ,
Kela drug reimbursment
Chronic disorders of vitamin D metabolism
+∞
26.3
23
*
J069, ,
ICD-O-3
+∞
26.3
23
*
N02AX02, ,
ATC
tramadol; systemic, rectal
+∞
25.0
22
*
Z011, ,
ICD-10 Finland
Examination of ears and hearing
+∞
25.0
22
*
M01AE02, ,
ATC
naproxen; oral, rectal
+∞
25.0
22
*
SDA03, ,
ICD-O-3
+∞
25.0
22
*
C10AA05, ,
ATC
atorvastatin; oral
+∞
25.0
22
*
127, ,
Kela drug reimbursment
Transplant complication
+∞
23.8
21
*
N189, ,
ICD-10 Finland
Chronic kidney disease, unspecified
+∞
23.8
21
*
WX408, ,
ICD-O-3
+∞
23.8
21
*
H02AB04, ,
ATC
methylprednisolone; systemic
+∞
23.8
21
*
A11CC03, ,
ATC
alfacalcidol; systemic
+∞
23.8
21
*
KMAK, ,
ICD-O-3
+∞
23.8
21
*
ZXA05, ,
ICD-O-3
+∞
23.8
21
*
Z940, ,
ICD-10 Finland
Kidney transplant status
+∞
23.8
21
*
C08CA01, ,
ATC
amlodipine; oral
+∞
23.8
21
*
Z315, ,
ICD-10 Finland
Genetic counselling
+∞
23.8
21
*
-1, ,
ICD-O-3
+∞
22.5
20
*
Z3226, ,
ICD-O-3
+∞
22.5
20
*
R5110, ,
ICD-O-3
+∞
22.5
20
*
WYA05, ,
ICD-O-3
+∞
22.5
20
*
E0000UV, ,
ATC
+∞
22.5
20
*
L04AA06, ,
ATC
mycophenolic acid; systemic
+∞
21.3
19
*
Z3229, ,
ICD-O-3
+∞
21.3
19
*
H02AB06, ,
ATC
prednisolone; systemic
+∞
21.3
19
*
SDA02, ,
ICD-O-3
+∞
21.3
19
*
138, ,
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
+∞
21.3
19
*
A12AA04, ,
ATC
calcium carbonate; oral
+∞
21.3
19
*
R104, ,
ICD-10 Finland
Other and unspecified abdominal pain
+∞
21.3
19
*
205, ,
Kela drug reimbursment
Chronic hypertension
+∞
21.3
19
*
L04AD02, ,
ATC
tacrolimus; systemic
+∞
21.3
19
*
SFA30, ,
ICD-O-3
+∞
21.3
19
*
JN3AE, ,
ICD-O-3
+∞
20.1
18
*
WZB00, ,
ICD-O-3
+∞
20.1
18
*
D82, ,
ICD-O-3
+∞
20.1
18
*
TPH15, ,
ICD-O-3
+∞
20.1
18
*
J01MA02, ,
ATC
ciprofloxacin; systemic
+∞
20.1
18
*
C07AB07, ,
ATC
bisoprolol; oral
+∞
20.1
18
*
ZXE20, ,
ICD-O-3
+∞
20.1
18
*
SCA01, ,
ICD-O-3
+∞
20.1
18
*
KA2AE, ,
ICD-O-3
+∞
18.9
17
*
M03BX02, ,
ATC
tizanidine; oral
+∞
18.9
17
*
SDA01, ,
ICD-O-3
+∞
18.9
17
*
WZA90, ,
ICD-O-3
+∞
18.9
17
*
J01FA06, ,
ATC
roxithromycin; oral
+∞
18.9
17
*
J069, ,
ICD-10 Finland
Acute upper respiratory infection, unspecified
+∞
18.9
17
*
EBA00, ,
ICD-O-3
+∞
18.9
17
*
WX402, ,
ICD-O-3
+∞
18.9
17
*
I10, ,
ICD-10 Finland
Essential (primary) hypertension
+∞
18.9
17
*
R06AE07, ,
ATC
cetirizine; oral
+∞
18.9
17
*
P01AB01, ,
ATC
metronidazole; oral, rectal
+∞
18.9
17
*
J01EE01, ,
ATC
sulfamethoxazole and trimethoprim; systemic
+∞
17.7
16
*
A02BC05, ,
ATC
esomeprazole; systemic
+∞
17.7
16
*
R74, ,
ICD-O-3
+∞
17.7
16
*
C10AA01, ,
ATC
simvastatin; oral
+∞
17.7
16
*
R31, ,
ICD-10 Finland
Unspecified haematuria
+∞
17.7
16
*
KAS10, ,
ICD-O-3
+∞
17.7
16
*
KH1AE, ,
ICD-O-3
+∞
17.7
16
*
KA2AT, ,
ICD-O-3
+∞
17.7
16
*
M01AH05, ,
ATC
etoricoxib; oral
+∞
17.7
16
*
DFF00, ,
ICD-O-3
+∞
17.7
16
*
Z2446, ,
ICD-O-3
+∞
16.5
15
*
UJD10, ,
ICD-O-3
+∞
16.5
15
*
FM1AE, ,
ICD-O-3
+∞
16.5
15
*
TK800, ,
ICD-O-3
+∞
16.5
15
*
J01EE02, ,
ATC
sulfadiazine and trimethoprim; systemic
+∞
16.5
15
*
A12AX, ,
ATC
Calcium, combinations with vitamin D and/or other drugs
+∞
16.5
15
*
S18, ,
ICD-O-3
+∞
16.5
15
*
SPAT1312, ,
ICD-O-3
+∞
16.5
15
*
Q8780, ,
ICD-O-3
+∞
16.5
15
*
C09CA06, ,
ATC
candesartan; oral
+∞
16.5
15
*
J01EA01, ,
ATC
trimethoprim; systemic
+∞
16.5
15
*
TPH04, ,
ICD-O-3
+∞
16.5
15
*
C09CA01, ,
ATC
losartan; oral
+∞
16.5
15
*
C09AA02, ,
ATC
enalapril; systemic
+∞
16.5
15
*
ZXD05, ,
ICD-O-3
+∞
16.5
15
*
R5140, ,
ICD-O-3
+∞
16.5
15
*
A03, ,
ICD-O-3
+∞
15.3
14
*
Z010, ,
ICD-10 Finland
Examination of eyes and vision
+∞
15.3
14
*
R06AX27, ,
ATC
desloratadine; oral
+∞
15.3
14
*
N02AJ06, ,
ATC
codeine and paracetamol; systemic
+∞
15.3
14
*
SPAT1256, ,
ICD-O-3
+∞
15.3
14
*
GD1UA, ,
ICD-O-3
+∞
15.3
14
*
R01AD12, ,
ATC
fluticasone furoate; nasal
+∞
15.3
14
*
SPAT1263, ,
ICD-O-3
+∞
15.3
14
*
M04AA01, ,
ATC
allopurinol; systemic
+∞
15.3
14
*
ZXA00, ,
ICD-O-3
+∞
15.3
14
*
M01AB05, ,
ATC
diclofenac; systemic, rectal
+∞
15.3
14
*
M796, ,
ICD-O-3
+∞
15.3
14
*
WX404, ,
ICD-O-3
+∞
15.3
14
*
R01AD09, ,
ATC
mometasone; nasal
+∞
15.3
14
*
Q878, ,
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
+∞
14.2
13
*
XF400, ,
ICD-O-3
+∞
14.2
13
*
DAX00, ,
ICD-O-3
+∞
14.2
13
*
137, ,
Kela drug reimbursment
Uraemia requiring dialysis
+∞
14.2
13
*
Z871, ,
ICD-O-3
+∞
14.2
13
*
Z974, ,
ICD-10 Finland
Presence of external hearing-aid
+∞
14.2
13
*
R21, ,
ICD-O-3
+∞
14.2
13
*
R5130, ,
ICD-O-3
+∞
14.2
13
*
N188, ,
ICD-10 Finland
Other chronic renal failure
+∞
14.2
13
*
SFC01, ,
ICD-O-3
+∞
14.2
13
*
J02AC01, ,
ATC
fluconazole; systemic
+∞
14.2
13
*
Q8788, ,
ICD-10 Finland
Other specified congenital malformation syndromes, not elsewhere classified
+∞
14.2
13
*
ZXA10, ,
ICD-O-3
+∞
14.2
13
*
FM1EE, ,
ICD-O-3
+∞
14.2
13
*
B03XA02, ,
ATC
darbepoetin alfa; parenteral
+∞
14.2
13
*
K021, ,
ICD-10 Finland
Caries of dentine
+∞
13.0
12
*
SDA04, ,
ICD-O-3
+∞
13.0
12
*
M796, ,
ICD-10 Finland
Pain in limb
+∞
13.0
12
*
Z018, ,
ICD-10 Finland
Other specified special examinations
+∞
13.0
12
*
PG1DE, ,
ICD-O-3
+∞
13.0
12
*
Z713, ,
ICD-10 Finland
Dietary counselling and surveillance
+∞
13.0
12
*
R5120, ,
ICD-O-3
+∞
13.0
12
*
J189, ,
ICD-10 Finland
Pneumonia, unspecified
+∞
13.0
12
*
Z718, ,
ICD-10 Finland
Other specified counselling
+∞
13.0
12
*
D07AC01, ,
ATC
betamethasone; topical
+∞
13.0
12
*
NK6QA, ,
ICD-O-3
+∞
13.0
12
*
S01XA20, ,
ATC
artificial tears and other indifferent preparations; ophthalmic
+∞
13.0
12
*
R05DA20, ,
ATC
opium alkaloids and derivatives - combinations
+∞
13.0
12
*
X59, ,
ICD-10 Finland
Exposure to unspecified factor
+∞
13.0
12
*
LC2BE, ,
ICD-O-3
+∞
13.0
12
*
OAB43, ,
ICD-O-3
+∞
13.0
12
*
Z508, ,
ICD-10 Finland
Care involving use of other rehabilitation procedures
+∞
13.0
12
*
SPAT1325, ,
ICD-O-3
+∞
13.0
12
*
UKC02, ,
ICD-O-3
+∞
13.0
12
*
J01MA12, ,
ATC
levofloxacin; systemic
+∞
11.9
11
*
D19, ,
ICD-O-3
+∞
11.9
11
*
B05DA, ,
ATC
Isotonic solutions
+∞
11.9
11
*
R83, ,
ICD-O-3
+∞
11.9
11
*
SFA00, ,
ICD-O-3
+∞
11.9
11
*
L17, ,
ICD-O-3
+∞
11.9
11
*
A09, ,
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
+∞
11.9
11
*
J01CA08, ,
ATC
pivmecillinam; oral
+∞
11.9
11
*
K020, ,
ICD-O-3
+∞
11.9
11
*
N02AA59, ,
ATC
codeine, combinations excl. psycholeptics; systemic
+∞
11.9
11
*
R509, ,
ICD-10 Finland
Fever, unspecified
+∞
11.9
11
*
N05CF01, ,
ATC
zopiclone; oral
+∞
11.9
11
*
190, ,
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
+∞
11.9
11
*
R05FA02, ,
ATC
opium derivatives and expectorants; systemic
+∞
11.9
11
*
WX002, ,
ICD-O-3
+∞
11.9
11
*
VALMI, ,
ICD-O-3
+∞
11.9
11
*
RD210, ,
ICD-O-3
+∞
10.8
10
*
SPAT1315, ,
ICD-O-3
+∞
10.8
10
*
K0364, ,
ICD-O-3
+∞
10.8
10
*
SDE03, ,
ICD-O-3
+∞
10.8
10
*
K0382, ,
ICD-O-3
+∞
10.8
10
*
C08CA13, ,
ATC
lercanidipine; oral
+∞
10.8
10
*
RS220, ,
ICD-O-3
+∞
10.8
10
*
I151, ,
ICD-10 Finland
Hypertension secondary to other renal disorders
+∞
10.8
10
*
Z492, ,
ICD-10 Finland
Other dialysis
+∞
10.8
10
*
DFF15, ,
ICD-O-3
+∞
10.8
10
*
H05BX01, ,
ATC
cinacalcet; oral
+∞
10.8
10
*
SDE02, ,
ICD-O-3
+∞
10.8
10
*
N390, ,
ICD-10 Finland
Urinary tract infection, site not specified
+∞
10.8
10
*
JN3AD, ,
ICD-O-3
+∞
10.8
10
*
A02BC01, ,
ATC
omeprazole; systemic
+∞
10.8
10
*
Z490, ,
ICD-10 Finland
Preparatory care for dialysis
+∞
10.8
10
*
R05, ,
ICD-O-3
+∞
10.8
10
*
K0510, ,
ICD-O-3
+∞
10.8
10
*
UJF32, ,
ICD-O-3
+∞
9.7
9
*
M255, ,
ICD-O-3
+∞
9.7
9
*
M01AC06, ,
ATC
meloxicam; systemic, rectal
+∞
9.7
9
*
NA3AA, ,
ICD-O-3
+∞
9.7
9
*
EBA10, ,
ICD-O-3
+∞
9.7
9
*
TPH07, ,
ICD-O-3
+∞
9.7
9
*
PH2AE, ,
ICD-O-3
+∞
9.7
9
*
D01AC20, ,
ATC
imidazoles/triazoles in combination with corticosteroids; topical
+∞
9.7
9
*
KA1AE, ,
ICD-O-3
+∞
9.7
9
*
M03BC51, ,
ATC
orphenadrine, combinations; systemic
+∞
9.7
9
*
SPAT1262, ,
ICD-O-3
+∞
9.7
9
*
L04AD01, ,
ATC
ciclosporin; systemic
+∞
9.7
9
*
G473, ,
ICD-10 Finland
Sleep apnoea
+∞
9.7
9
*
196, ,
Kela drug reimbursment
Paricalcitol and cinacalcet
+∞
9.7
9
*
B05DB, ,
ATC
Hypertonic solutions
+∞
9.7
9
*
B01AB05, ,
ATC
enoxaparin; parenteral
+∞
9.7
9
*
K045, ,
ICD-O-3
+∞
9.7
9
*
WZC30, ,
ICD-O-3
+∞
9.7
9
*
D07AB02, ,
ATC
hydrocortisone butyrate; topical
+∞
9.7
9
*
ZXD20, ,
ICD-O-3
+∞
9.7
9
*
ZX120, ,
ICD-O-3
+∞
9.7
9
*
M01AE03, ,
ATC
ketoprofen; systemic, rectal
+∞
9.7
9
*
PBL10, ,
ICD-O-3
+∞
9.7
9
*
N10, ,
ICD-10 Finland
Acute tubulo-interstitial nephritis
+∞
9.7
9
*
C09AA05, ,
ATC
ramipril; oral
+∞
9.7
9
*
J01FA01, ,
ATC
erythromycin; systemic
+∞
9.7
9
*
SPAT1249, ,
ICD-O-3
+∞
9.7
9
*
A06AC01, ,
ATC
ispaghula (psylla seeds); oral
+∞
9.7
9
*
L15, ,
ICD-O-3
+∞
8.6
8
*
WW500, ,
ICD-O-3
+∞
8.6
8
*
N05AH04, ,
ATC
quetiapine; oral
+∞
8.6
8
*
S29, ,
ICD-O-3
+∞
8.6
8
*
SPAT1316, ,
ICD-O-3
+∞
8.6
8
*
X58, ,
ICD-10 Finland
Exposure to other specified factors
+∞
8.6
8
*
E000001, ,
ATC
+∞
8.6
8
*
SPAT1310, ,
ICD-O-3
+∞
8.6
8
*
320, ,
Kela drug reimbursment
Lanthanum carbonate, sevelamer and sucroferric oxyhydroxide
+∞
8.6
8
*
SAD01, ,
ICD-O-3
+∞
8.6
8
*
SGB10, ,
ICD-O-3
+∞
8.6
8
*
H03AA01, ,
ATC
levothyroxine sodium; systemic
+∞
8.6
8
*
K210, ,
ICD-10 Finland
Gastro-oesophageal reflux disease with oesophagitis
+∞
8.6
8
*
R03BA02, ,
ATC
budesonide; inhalant
+∞
8.6
8
*
H660, ,
ICD-10 Finland
Acute suppurative otitis media
+∞
8.6
8
*
V03AE01, ,
ATC
polystyrene sulfonate; oral
+∞
8.6
8
*
S01GX01, ,
ATC
cromoglicic acid; ophthalmic
+∞
8.6
8
*
H01, ,
ICD-O-3
+∞
8.6
8
*
R01AD08, ,
ATC
fluticasone; nasal
+∞
8.6
8
*
LX1AE, ,
ICD-O-3
+∞
8.6
8
*
SPAT1317, ,
ICD-O-3
+∞
8.6
8
*
HMAK, ,
ICD-O-3
+∞
8.6
8
*
203, ,
Kela drug reimbursment
Chronic asthma and similar chronic obstructive pulmonary diseases
+∞
8.6
8
*
Z035, ,
ICD-10 Finland
Observation for other suspected cardiovascular diseases
+∞
8.6
8
*
SBB10, ,
ICD-O-3
+∞
8.6
8
*
R05FB02, ,
ATC
cough suppressants and expectorants; systemic
+∞
8.6
8
*
R03CC02, ,
ATC
salbutamol; systemic
+∞
8.6
8
*
Z0389, ,
ICD-10 Finland
Observation for other suspected diseases and conditions
+∞
8.6
8
*
C10AX09, ,
ATC
ezetimibe; oral
+∞
8.6
8
*
A499, ,
ICD-10 Finland
Bacterial infection, unspecified
+∞
8.6
8
*
H521, ,
ICD-10 Finland
Myopia
+∞
8.6
8
*
SGA02, ,
ICD-O-3
+∞
8.6
8
*
Z363, ,
ICD-10 Finland
Antenatal screening for malformations using ultrasound and other physical methods
+∞
8.6
8
*
D01, ,
ICD-O-3
+∞
8.6
8
*
U071, ,
ICD-10 Finland
Emergency use of U07.1 | COVID-19, virus identified
+∞
8.6
8
*
NH3AA, ,
ICD-O-3
+∞
8.6
8
*
K0532, ,
ICD-O-3
+∞
8.6
8
*
N06AX11, ,
ATC
mirtazapine; oral
+∞
8.6
8
*
U072, ,
ICD-10 Finland
COVID-19, virus not identified
+∞
8.6
8
*
SPAT1301, ,
ICD-O-3
+∞
8.6
8
*
M02AA07, ,
ATC
piroxicam; topical
+∞
8.6
8
*
Z2445, ,
ICD-O-3
+∞
8.6
8
*
Z712, ,
ICD-10 Finland
Person consulting for explanation of investigation findings
+∞
8.6
8
*
Z491, ,
ICD-10 Finland
Extracorporeal dialysis
+∞
8.6
8
*
TLC00, ,
ICD-O-3
+∞
7.5
7
*
Z712, ,
ICD-O-3
+∞
7.5
7
*
GD1PA, ,
ICD-O-3
+∞
7.5
7
*
Z461, ,
ICD-10 Finland
Fitting and adjustment of hearing aid
+∞
7.5
7
*
J459, ,
ICD-10 Finland
Asthma, unspecified
+∞
7.5
7
*
R01BA51, ,
ATC
phenylpropanolamine, combinations; oral
+∞
7.5
7
*
H13, ,
ICD-O-3
+∞
7.5
7
*
K650, ,
ICD-10 Finland
Acute peritonitis
+∞
7.5
7
*
R4190, ,
ICD-O-3
+∞
7.5
7
*
N03AX16, ,
ATC
[U] pregabalin
+∞
7.5
7
*
R01BA52, ,
ATC
pseudoephedrine, combinations; oral
+∞
7.5
7
*
R103, ,
ICD-10 Finland
Pain localized to other parts of lower abdomen
+∞
7.5
7
*
WZC05, ,
ICD-O-3
+∞
7.5
7
*
TK820, ,
ICD-O-3
+∞
7.5
7
*
C07AG02, ,
ATC
carvedilol; oral
+∞
7.5
7
*
C10AA07, ,
ATC
rosuvastatin; oral
+∞
7.5
7
*
G04CA02, ,
ATC
tamsulosin; oral
+∞
7.5
7
*
V03AE02, ,
ATC
sevelamer; oral
+∞
7.5
7
*
WX006, ,
ICD-O-3
+∞
7.5
7
*
DCA20, ,
ICD-O-3
+∞
7.5
7
*
N05BA04, ,
ATC
oxazepam; oral
+∞
7.5
7
*
WW200, ,
ICD-O-3
+∞
7.5
7
*
JN1AE, ,
ICD-O-3
+∞
7.5
7
*
EBA05, ,
ICD-O-3
+∞
7.5
7
*
J01FA09, ,
ATC
clarithromycin; systemic
+∞
7.5
7
*
XCW99, ,
ICD-O-3
+∞
7.5
7
*
AA1AD, ,
ICD-O-3
+∞
7.5
7
*
G03CA03, ,
ATC
estradiol; nasal, systemic, rectal, transdermal, vaginal
+∞
7.5
7
*
SPAT1253, ,
ICD-O-3
+∞
7.5
7
*
R104, ,
ICD-O-3
+∞
7.5
7
*
KBV00, ,
ICD-O-3
+∞
7.5
7
*
SGC00, ,
ICD-O-3
+∞
7.5
7
*
Z012, ,
ICD-10 Finland
Dental examination
+∞
7.5
7
*
SPAT1283, ,
ICD-O-3
+∞
7.5
7
*
A02BC03, ,
ATC
lansoprazole; oral
+∞
7.5
7
*
C10AA04, ,
ATC
fluvastatin; oral
+∞
7.5
7
*
U072, ,
ICD-O-3
+∞
7.5
7
*
N06AB10, ,
ATC
escitalopram; oral
+∞
7.5
7
*
SPAT1363, ,
ICD-O-3
+∞
7.5
7
*
321, ,
Kela drug reimbursment
Paricalcitol and cinacalcet
+∞
7.5
7
*
XF600, ,
ICD-O-3
+∞
7.5
7
*
F3210, ,
ICD-10 Finland
Moderate depressive episode without somatic syndrome
+∞
7.5
7
*
OAA65, ,
ICD-O-3
+∞
7.5
7
*
R02, ,
ICD-O-3
+∞
7.5
7
*
E785, ,
ICD-10 Finland
Hyperlipidaemia, unspecified
+∞
7.5
7
*
R509, ,
ICD-O-3
+∞
7.5
7
*
S0251, ,
ICD-O-3
+∞
7.5
7
*
WZC10, ,
ICD-O-3
+∞
7.5
7
*
Z001, ,
ICD-O-3
+∞
7.5
7
*
H669, ,
ICD-O-3
+∞
7.5
7
*
L04AA01, ,
ATC
[U] ciclosporin
+∞
6.4
6
*
SCA02, ,
ICD-O-3
+∞
6.4
6
*
C09AA03, ,
ATC
lisinopril; oral
+∞
6.4
6
*
C02AC05, ,
ATC
moxonidine; oral
+∞
6.4
6
*
Z760, ,
ICD-O-3
+∞
6.4
6
*
KC1EE, ,
ICD-O-3
+∞
6.4
6
*
WYA30, ,
ICD-O-3
+∞
6.4
6
*
R5180, ,
ICD-10 Finland
Headache
+∞
6.4
6
*
E000002, ,
ATC
+∞
6.4
6
*
N180, ,
ICD-10 Finland
End-stage renal disease
+∞
6.4
6
*
K0365, ,
ICD-O-3
+∞
6.4
6
*
U071, ,
ICD-O-3
+∞
6.4
6
*
M05BA04, ,
ATC
alendronic acid; oral
+∞
6.4
6
*
U02, ,
ICD-O-3
+∞
6.4
6
*
N19, ,
ICD-10 Finland
Unspecified kidney failure
+∞
6.4
6
*
P03, ,
ICD-O-3
+∞
6.4
6
*
WX892, ,
ICD-O-3
+∞
6.4
6
*
R03AK07, ,
ATC
formoterol and budesonide; inhalant
+∞
6.4
6
*
ZXD30, ,
ICD-O-3
+∞
6.4
6
*
KA9AE, ,
ICD-O-3
+∞
6.4
6
*
N05CF02, ,
ATC
zolpidem; oral
+∞
6.4
6
*
J01DA08, ,
ATC
[U] cefaclor
+∞
6.4
6
*
Z004, ,
ICD-10 Finland
General psychiatric examination, not elsewhere classified
+∞
6.4
6
*
R103, ,
ICD-O-3
+∞
6.4
6
*
R06AE09, ,
ATC
levocetirizine; oral
+∞
6.4
6
*
L12, ,
ICD-O-3
+∞
6.4
6
*
R03DC03, ,
ATC
montelukast; oral
+∞
6.4
6
*
R2130, ,
ICD-O-3
+∞
6.4
6
*
U14, ,
ICD-O-3
+∞
6.4
6
*
KF8AE, ,
ICD-O-3
+∞
6.4
6
*
103, ,
Kela drug reimbursment
Diabetes, insulin-treated
+∞
6.4
6
*
M03BC01, ,
ATC
orphenadrine (citrate); systemic
+∞
6.4
6
*
O800, ,
ICD-10 Finland
Spontaneous vertex delivery
+∞
6.4
6
*
T90, ,
ICD-O-3
+∞
6.4
6
*
H653, ,
ICD-10 Finland
Chronic mucoid otitis media
+∞
6.4
6
*
NF1AA, ,
ICD-O-3
+∞
6.4
6
*
CJE20, ,
ICD-O-3
+∞
6.4
6
*
S21, ,
ICD-O-3
+∞
6.4
6
*
M02AA10, ,
ATC
ketoprofen; topical
+∞
6.4
6
*
78930, ,
ICD-8 Finland
Abnormal urinary constituents of unspecified cause, Haematuria
+∞
6.4
6
*
A10BA02, ,
ATC
metformin; oral
+∞
6.4
6
*
TJA35, ,
ICD-O-3
+∞
6.4
6
*
RK110, ,
ICD-O-3
+∞
6.4
6
*
K0408, ,
ICD-O-3
+∞
6.4
6
*
SPAT1223, ,
ICD-O-3
+∞
6.4
6
*
SPAT1156, ,
ICD-O-3
+∞
6.4
6
*
F329, ,
ICD-10 Finland
Depressive episode, unspecified
+∞
6.4
6
*
J01FF01, ,
ATC
clindamycin; systemic
+∞
6.4
6
*
E6601, ,
ICD-10 Finland
Obesity due to excess calories
+∞
6.4
6
*
SAB01, ,
ICD-O-3
+∞
6.4
6
*
K573, ,
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
+∞
6.4
6
*
J01DA09, ,
ATC
[U] cefadroxil
+∞
6.4
6
*
M01AH01, ,
ATC
celecoxib; oral
+∞
6.4
6
*
A09, ,
ICD-O-3
+∞
6.4
6
*
J189, ,
ICD-O-3
+∞
6.4
6
*
SFA40, ,
ICD-O-3
+∞
6.4
6
*
E119, ,
ICD-10 Finland
Type 2 diabetes mellitus, without complications
+∞
6.4
6
*
MA2AE, ,
ICD-O-3
+∞
6.4
6
*
R074, ,
ICD-10 Finland
Chest pain, unspecified
+∞
6.4
6
*
D07AC13, ,
ATC
mometasone; topical
+∞
6.4
6
*
XKD00, ,
ICD-O-3
+∞
6.4
6
*
J05AB01, ,
ATC
aciclovir; systemic
+∞
6.4
6
*
L08, ,
ICD-O-3
+∞
6.4
6
*
J450, ,
ICD-10 Finland
Predominantly allergic asthma
+∞
6.4
6
*
TQX10, ,
ICD-O-3
+∞
6.4
6
*
D649, ,
ICD-10 Finland
Anaemia, unspecified
+∞
6.4
6
*
A10BK01, ,
ATC
dapagliflozin; oral
+∞
6.4
6
*
Z000, ,
ICD-10 Finland
General medical examination
+∞
6.4
6
*
SPAT1153, ,
ICD-O-3
+∞
6.4
6
*
JAK10, ,
ICD-O-3
+∞
6.4
6
*
F29, ,
ICD-O-3
+∞
6.4
6
*
LabWAS
↥OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
cases
controls
unit
-log10(p)
N cases
N controls
34
32
28.81
35.23
15.6
8.7
11.92
6.51
mmol/l
3.59
34
32
26
17
29.12
18.87
8.6
12.2
1.83
1.24
mg/l
0.98
26
17
30
55
11.53
18.26
6.3
2.6
1.16
1.09
e6/l
0.03
20
32
31
61
11.11
17.72
5.9
2.6
0.40
0.55
e6/l
0.33
20
38
38
100
11.40
16.66
10.6
2.6
0.04
0.21
e6/l
1.21
33
81
43
126
14.85
16.09
11.5
2.8
—
—
—
0
0
40
134
9.60
13.15
12.4
5.2
35.90
37.82
g/l
1.56
40
129
19
22
12.91
10.47
4.8
1.5
46.11
69.80
ml/min/173m2
—
9
10
42
177
8.14
9.98
8.1
2.9
0.00
0.00
estimate
—
10
37
42
180
7.93
9.70
12.0
4.0
0.00
0.00
estimate
—
10
36
42
180
7.93
9.70
8.1
2.9
0.00
0.00
estimate
—
10
33
36
143
5.93
8.79
5.0
2.6
68.56
68.92
nmol/l
0.03
36
132
19
33
8.44
8.27
11.3
8.8
23.93
24.45
mmol/l
0.19
19
33
17
43
5.39
6.80
3.2
2.0
—
—
—
0
0
17
36
6.49
6.36
11.6
6.9
102.06
103.97
mmol/l
0.61
17
36
8
5
18.50
5.60
2.0
1.6
—
—
—
0
0
10
11
10.92
5.57
8.8
10.3
0.61
0.72
%
—
10
11
9
8
13.26
5.53
1.3
1.1
—
—
—
0
0
9
8
13.26
5.53
1.3
1.1
—
—
—
0
0
10
12
9.99
5.34
8.8
9.5
1.12
2.59
%
—
10
12
14
29
6.20
5.30
3.1
1.5
—
—
—
0
0
14
29
6.20
5.30
3.1
1.6
—
—
—
0
0
11
16
8.39
5.28
3.6
1.5
—
—
—
0
0
11
16
8.39
5.28
2.6
1.0
—
—
—
0
0
14
31
5.78
5.03
4.4
2.8
—
—
—
0
0
23
91
3.74
5.00
5.7
2.4
2.31
2.35
mmol/l
0.53
23
84
34
175
3.72
4.92
8.0
2.7
194.40
80.18
ug/l
0.75
34
168
10
14
8.54
4.92
9.5
4.4
21.12
23.24
mmol/l
—
10
14
10
15
7.96
4.73
2.7
1.6
—
—
—
0
0
10
16
7.45
4.55
2.8
1.3
—
—
—
0
0
7
6
13.19
4.41
1.0
7.0
53.66
26.78
mg/l
—
7
6
7
6
13.19
4.41
1.0
7.0
61.49
34.75
mg/l
—
7
6
43
285
3.93
4.02
14.4
7.1
90.53
83.92
u/l
0.28
43
274
23
109
2.99
3.54
2.7
2.5
76.00
54.38
u/l
0.89
23
104
20
90
2.99
3.34
2.9
2.6
—
—
—
0
0
24
124
2.74
3.07
17.6
5.7
0.87
1.10
inr
—
6
31
8
17
5.35
3.05
3.0
1.8
—
—
—
0
0
19
93
2.64
2.64
8.4
3.1
0.00
0.00
estimate
—
10
34
6
11
6.00
2.62
1.3
3.5
3.42
2.95
g/l
—
6
11
6
11
6.00
2.62
1.3
3.5
7.13
10.83
g/l
—
6
11
6
11
6.00
2.62
1.3
3.5
—
—
—
0
0
6
11
6.00
2.62
1.3
3.5
7.50
7.54
g/l
—
6
11
6
11
6.00
2.62
1.3
3.5
3.18
4.04
g/l
—
6
11
6
13
5.06
2.34
7.3
3.1
58.12
41.02
%
—
6
13
5
11
4.90
1.99
1.4
3.5
0.00
0.00
g/l
—
5
11
5
11
4.90
1.99
1.4
3.5
37.48
39.45
g/l
—
5
11
5
11
4.90
1.99
1.4
3.5
0.00
0.00
g/l
—
5
11
5
11
4.90
1.99
1.4
3.5
0.00
0.00
g/l
—
5
11
5
11
4.90
1.99
1.4
3.5
0.00
0.00
g/l
—
5
11
34
246
2.10
1.72
15.0
12.0
3.86
3.97
e9/l
0.13
27
216
45
378
2.41
1.51
6.8
3.4
4.59
4.67
mmol/l
0.22
45
363
22
141
1.97
1.50
9.0
2.8
—
—
—
0
0
18
108
2.02
1.47
2.1
1.7
110.71
97.04
pmol/l
—
7
58
44
367
2.29
1.46
5.9
3.1
1.44
1.33
mmol/l
0.60
44
349
22
143
1.93
1.43
2.3
3.3
28.59
30.37
u/l
0.20
22
135
45
380
2.37
1.35
6.8
3.6
2.74
2.84
mmol/l
0.32
45
364
44
377
2.08
1.16
6.7
3.3
1.33
1.43
mmol/l
1.21
44
360
25
182
1.72
1.07
3.1
2.6
—
—
—
0
0
0
30
0.00
1.01
0.0
1.5
—
—
—
0
0
6
31
2.05
0.87
1.3
1.2
—
—
—
0
0
0
25
0.00
0.81
0.0
1.6
—
—
—
0
0
0
25
0.00
0.81
0.0
1.6
—
—
—
0
0
0
25
0.00
0.81
0.0
1.6
—
—
—
0
0
12
76
1.75
0.80
1.8
3.0
0.87
1.84
mg/l
0.42
12
61
41
357
1.70
0.76
5.7
3.1
5.59
5.71
mmol/l
0.35
41
339
0
22
0.00
0.61
0.0
1.3
—
5.43
—
0
13
42
376
1.61
0.60
4.1
3.7
—
—
—
0
0
32
364
0.69
0.57
5.6
4.3
1.93
1.82
mu/l
0.22
32
345
0
18
0.00
0.40
0.0
1.7
—
2.47
—
0
13
0
11
0.00
0.21
0.0
2.3
—
—
—
0
0
0
10
0.00
0.21
0.0
1.1
—
5.30
—
0
10
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
5
66
0.73
0.18
1.6
1.3
—
—
—
0
0
47
453
1.39
0.18
20.1
8.8
27.34
29.12
u/l
0.29
47
442
33
310
1.18
0.16
3.4
3.3
55.79
36.53
u/l
0.56
33
305
29
308
0.87
0.13
4.8
3.8
14.69
14.83
pmol/l
0.11
29
292
11
97
1.17
0.10
4.5
3.8
2.34
1.50
ug/l
0.28
11
90
30
286
1.12
0.09
4.4
3.6
19.30
7.23
mm/h
2.77
30
272
12
130
0.90
0.05
1.7
1.5
—
—
—
0
0
0
6
0.00
0.00
0.0
1.3
—
—
—
0
0
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
0
7
0.00
0.00
0.0
2.4
—
—
—
0
0
0
9
0.00
-0.00
0.0
2.6
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
8
0.00
-0.00
0.0
1.4
—
51.25
—
0
8
0
5
0.00
-0.00
0.0
1.0
—
13.20
—
0
5
0
5
0.00
-0.00
0.0
1.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
0
5
0.00
-0.00
0.0
1.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.2
—
—
—
0
0
0
5
0.00
-0.00
0.0
2.4
—
—
—
0
0
Mortality – FinRegistry
↥This endpoint is excluded (different definition than used in FinnGen).
Relationships between endpoints
↥Index endpoint: Q17_ALPORT – Alport
GWS hits: -
This endpoint is excluded (different definition than used in FinnGen).